Cathepsin G, a leukocyte protease, activates coagulation factor VIII

Summary

Neutrophils and monocytes express cathepsin G and can also bind to activated platelets, thus they can be localized to the site of active coagulation. Previous studies have suggested that cathepsin G inactivated coagulation factorVIII (FVIII) and was thus anticoagulant. But other studies have indicated procoagulant functions for cathepsin G in activation of coagulation factorV or activation of platelets among other possible mechanisms. Therefore, it remains unclear if cathepsin G is anticoagulant or procoagulant. We investigated the effects of human neutrophil cathepsin G on FVIII/VIIIa. Cathepsin G activates FVIII to a partially active form while having only a minor inactivating effect on thrombin- activated FVIIIa. This inactivation is mostly due to decreased stability of FVIIIa since a disulfide bond that prevents A2 subunit dissociation from FVIIIa prevents any loss of activity due to cathepsin G proteolysis. FVIII that has been cleaved by cathepsin G can still be activated by thrombin if A2 subunit dissociation is prevented. Cathepsin G cleavages of FVIII are limited to a few specific sites that are mostly located near known activating and inactivating cleavage sites. Cathepsin G cleavage sites near to thrombin cleavage sites likely contribute to the partial activation of FVIII. Therefore, it is possible that cathepsin G from neutrophils and monocytes may provide some pro-coagulant effect by activating FVIII.

Keywords

Factor VIII - cathepsin G - thrombosis - inflammation - neutrophils

 

• References

• 1 Gillis S, Furie BC, Furie B. Interactions of neutrophils and coagulation proteins. Semin Hematol 1997; 34: 336-342.
• 2 Travis J. Structure, function, and control of neutrophil proteinases. Am J Med 1988; 84: 37-42.
• 3 Allen DH, Tracy PB. Human coagulation factor is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface. J Biol Chem 1995; 270: 1408-1415.
• 4 Owen CA, Campbell MA, Sannes PL. et al. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol 1995; 131: 775-789.
• 5 Sambrano GR, Huang W, Faruqi T. et al. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 2000; 275: 6819-6823.
• 6 Goel MS, Diamond SL. Neutrophil cathepsin promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets. J Biol Chem 2003; 278: 9458-9463.
• 7 Bagoly Z, Haramura G, Muszbek L. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot. Thromb Haemost 2007; 98: 359-367.
• 8 Vehar GA, Davie EW. Preparation and properties of bovine factor VIII. Biochemistry 1980; 19: 401-410.
• 9 Eaton D, Rodriquez H, Vehar GA. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry 1986; 25: 505-512.
• 10 Lollar P, Knutson GJ, Fass DN. Activation of porcine factor VIII:C by thrombin and factor Xa. Biochemistry 1985; 24: 8056-8064.
• 11 Lollar P, Parker CG. Subunit structure of thrombinactivated porcine factor VIII. Biochemistry 1989; 28: 666-674.
• 12 Fay PJ, Haidaris PJ, Smudzin TM. Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem 1991; 266: 8957-8962.
• 13 Lollar P, Parker ET, Fay PJ. Coagulant properties of hybrid human/porcine factor VIII molecules. J Biol Chem 1992; 267: 23652-23657.
• 14 Pipe SW, Eickhorst AN, McKinley SH. et al. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo. Blood 1999; 93: 176-183.
• 15 Samis JA, Garrett M, Manuel RP. et al. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V. Blood 1997; 90: 1065-1074.
• 16 Camire RM, Kalafatis M, Tracy PB. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding. Biochemistry 1998; 37: 11896-11906.
• 17 Plescia J, Altieri DC. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J 1996; 319 ( Pt 3): 873-879.
• 18 McGee MP, Li LC. Functional difference between intrinsic and extrinsic coagulation pathways. Kinetics of factor X activation on human monocytes and alveolar macrophages. J Biol Chem 1991; 266: 8079-8085.
• 19 Bouchard BA, Tracy PB. The participation of leukocytes in coagulant reactions. J Thromb Haemost 2003; 1: 464-469.
• 20 Egbring R, Havemann K. Possible role of polymorphonuclear granulocyte proteases in blood coagulation. Havemann K, Janoff AS. editors. Neutral proteases of human polymorphonuclear leukocytes.. Baltimore-Munich: Urban & Schwarzenberg, Inc.; 1978: 442-458.
• 21 Kopec M, Bykowska K, Lopaciuk S. et al. Effects of neutral proteases from human leukocytes on structure and biological properties of human factor VIII. Thromb Haemost 1980; 43: 211-217.
• 22 Varadi K, Marossy K, Asboth G. et al. Inactivation of human Factor VIII by granulocyte proteases. Thromb Haemost 1980; 43: 45-48.
• 23 Fay PJ. Activation of factor VIII and mechanisms of cofactor action. Blood Rev 2004; 18: 1-15.
• 24 Gale AJ, Radtke KP, Cunningham MA. et al. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants. J Thromb Haemost 2006; 4: 1315-1322.
• 25 Gale AJ, Pellequer JL. An engineered interdomain disulfide bond stabilizes human blood coagulation factor VIIIa. J Thromb Haemost 2003; 1: 1966-1971.
• 26 Mesters RM, Houghten RA, Griffin JH. Identification of a sequence of human activated protein C (residues 390–404) essential for its anticoagulant activity. J Biol Chem 1991; 266: 24514-24519.
• 27 Hill-Eubanks DC, Parker CG, Lollar P. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin. Proc Natl Acad Sci USA 1989; 86: 6508-6512.
• 28 Polanowska J, Krokoszynska I, Czapinska H. et al. Specificity of human cathepsin G. Biochim Biophys Acta 1998; 1386: 189-198.
• 29 Regan LM, Fay PJ. Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity. J Biol Chem 1995; 270: 8546-8552.
• 30 Fay PJ, Mastri M, Koszelak ME. et al. Cleavage of factor VIII heavy chain is required for the functional interaction of a2 subunit with factor IXA. J Biol Chem 2001; 276: 12434-12439.
• 31 Koszelak Rosenblum ME, Schmidt K, Freas J. et al. Cofactor activities of factor VIIIa and A2 subunit following cleavage of A1 subunit at Arg336. J Biol Chem 2002; 277: 11664-11669.
• 32 Nogami K, Wakabayashi H, Schmidt K. et al. Altered interactions between the A1 and A2 subunits of factor VIIIa following cleavage of A1 subunit by factor Xa. J Biol Chem 2003; 278: 1634-1641.
• 33 Nogami K, Wakabayashi H, Fay PJ. Mechanisms of factor Xa-catalyzed cleavage of the factor VIIIa A1 subunit resulting in cofactor inactivation. J Biol Chem 2003; 278: 16502-16509.
• 34 Parker ET, Pohl J, Blackburn MN. et al. Subunit structure and function of porcine factor Xa-activated factor VIII. Biochemistry 1997; 36: 9365-9373.
• 35 Owen CA, Campbell EJ. The cell biology of leukocyte- mediated proteolysis. J Leukoc Biol 1999; 65: 137-150.
• 36 Campbell EJ, Owen CA. The sulfate groups of chondroitin sulfate- and heparan sulfate-containing proteoglycans in neutrophil plasma membranes are novel binding sites for human leukocyte elastase and cathepsin G. J Biol Chem 2007; 282: 14645-14654.